DNA constructs eliciting immune response against flavivirus and effective adjuvants

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8961994
APP PUB NO 20110262394A1
SERIAL NO

13129599

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Aspects of the present invention relate to isolated nucleic acids that encode a consensus DIII domain of protein E and vaccines made using same, and also methods for using the aforementioned to generate in a host an immune response against multiple serotypes of flavivirus, particularly West Nile virus and Japanese encephalitis virus.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VGX PHARMACEUTICALS LLC450 SENTRY PARKWAY BLUE BELL PA 19422

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ramanathan, Mathura P Ardmore, US 16 40
Sardesai, Niranjan Y Blue Bell, US 30 172

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 24, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00